Pathologie Friesland Migrates to Proscia’s Concentriq for Scalable Digital Pathology
Event summary
- Pathologie Friesland, a Dutch pathology lab, is switching to Proscia’s Concentriq AP-Dx platform to support growth and AI integration.
- The lab processes hundreds of thousands of images annually for hospitals, GPs, and clinics in the Netherlands.
- Concentriq AP-Dx was chosen for its scalability, interoperability, and AI capabilities, with deployment on AWS.
- Pathologie Friesland will start with Proscia’s quality control AI application as a first step.
The big picture
Pathologie Friesland’s shift to Concentriq AP-Dx reflects a broader trend in pathology labs adopting scalable, AI-ready platforms to meet rising diagnostic demands. The migration underscores the growing importance of cloud-based solutions and interoperability in healthcare diagnostics. Proscia’s win highlights its competitive edge in digital pathology, particularly in Europe.
What we're watching
- AI Integration Pace
- How quickly Pathologie Friesland can operationalize AI applications beyond quality control.
- Scalability Impact
- Whether Concentriq AP-Dx can effectively support the lab’s expansion across new sites and workflows.
- Competitive Positioning
- How this move strengthens Proscia’s market share in digital pathology platforms in Europe.
Related topics